METASTATIC PAPILLARY RENAL CELL CARCINOMA
Clinical trials for METASTATIC PAPILLARY RENAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC PAPILLARY RENAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC PAPILLARY RENAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gut bacteria boost: could a probiotic supercharge cancer treatment?
Disease control OngoingThis early-stage study is testing if adding a probiotic called CBM588 to standard cancer drugs (cabozantinib and nivolumab) can help patients with advanced kidney cancer. The probiotic aims to improve the mix of 'good' bacteria in the gut, which might help the body's immune syste…
Matched conditions: METASTATIC PAPILLARY RENAL CELL CARCINOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New hope for tough kidney cancer: can a combo therapy outperform standard care?
Disease control OngoingThis study is for people with advanced papillary kidney cancer that has spread. It compares the standard drug cabozantinib alone against cabozantinib combined with a newer immunotherapy drug called atezolizumab. The goal is to see if the two-drug combination can better control th…
Matched conditions: METASTATIC PAPILLARY RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC